Skip to content

Efficacy of Perioperative Intravenous Lidocaine Infusion on Postoperative Pulmonary Complications Undergoing Video-Assisted Thoracoscopic Lung Resection Surgery: a Randomized Controlled Trial

Efficacy of Perioperative Intravenous Lidocaine Infusion on Postoperative Pulmonary Complications Undergoing Video-Assisted Thoracoscopic Lung Resection Surgery: a Randomized Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061979
Enrollment
Unknown
Registered
2022-07-15
Start date
2022-08-10
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung disease

Interventions

Group 1 :1% lidocaine(1.5 mg/kg) is administrated intravenously at the induction of general anesthesia, followed by continuous infusion of 1% lidocaine at 1.5 mg/kg/h until the end of surgery
Control 2:At the anesthesia induction and during surgery, the same volume of 0.9% normal saline is given

Sponsors

Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who plan to undergo elective thoracoscopic surgery in the Department of Thoracic Surgery of Sichuan Provincial People's Hospital; 2. 18 years old <= age <= 80 years old; 3. ASA classification: I-III level; 4. Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those with severe mental illness, such as schizophrenia, depression, dementia, etc.; 2. Combined with severe hepatic insufficiency (AST or ALT or bilirubin greater than 2.5 times the upper limit of normal), severe renal insufficiency (creatinine clearance rate less than 60 ml/min); 3. Those who are allergic to amide local anesthetics or have a history of epileptic seizures with II/III° atrioventricular block, severe sinus bradycardia or sick sinus syndrome; 4. Patients with Asperger's syndrome, pre-excitation syndrome, and severe heart block (including sinoatrial, atrioventricular, and intraventricular block); 5. History of taking chronic analgesics, opioid dependence.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative pulmonary complications within 7days after surgery;

Secondary

MeasureTime frame
Postoperative Recovery Quality (QoR-40);Incidence of moderate to severe pain of 24h postoperatively at rest and during motion;Incidence of moderate to severe pain of 48h postoperatively at rest and during motion;The number of patients who need remedial analgesics;Adverse events of analgesics;The length of hospital stays;

Countries

China

Contacts

Public ContactZeng Si

Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital

1906323512@qq.com+86 17708130275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026